200 related articles for article (PubMed ID: 23028736)
1. In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice.
von Elverfeldt D; von zur Muhlen C; Wiens K; Neudorfer I; Zirlik A; Meissner M; Tilly P; Charles AL; Bode C; Peter K; Fabre JE
PLoS One; 2012; 7(9):e45008. PubMed ID: 23028736
[TBL] [Abstract][Full Text] [Related]
2. An approach towards molecular imaging of activated platelets allows imaging of symptomatic human carotid plaques in a new model of a tissue flow chamber.
von Elverfeldt D; Meissner M; Peter K; Paul D; Meixner F; Neudorfer I; Merkle A; Harloff A; Zirlik A; Schöllhorn J; Markl M; Hennig J; Bode C; von zur Muhlen C
Contrast Media Mol Imaging; 2012; 7(2):204-13. PubMed ID: 22434633
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis.
von zur Muhlen C; von Elverfeldt D; Moeller JA; Choudhury RP; Paul D; Hagemeyer CE; Olschewski M; Becker A; Neudorfer I; Bassler N; Schwarz M; Bode C; Peter K
Circulation; 2008 Jul; 118(3):258-67. PubMed ID: 18574047
[TBL] [Abstract][Full Text] [Related]
4. Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis.
Duerschmied D; Meißner M; Peter K; Neudorfer I; Roming F; Zirlik A; Bode C; von Elverfeldt D; von Zur Muhlen C
Invest Radiol; 2011 Oct; 46(10):618-23. PubMed ID: 21577120
[TBL] [Abstract][Full Text] [Related]
5. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa.
von zur Muhlen C; Peter K; Ali ZA; Schneider JE; McAteer MA; Neubauer S; Channon KM; Bode C; Choudhury RP
J Vasc Res; 2009; 46(1):6-14. PubMed ID: 18515970
[TBL] [Abstract][Full Text] [Related]
6. Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths.
von Zur Muhlen C; von Elverfeldt D; Choudhury RP; Ender J; Ahrens I; Schwarz M; Hennig J; Bode C; Peter K
Mol Imaging; 2008; 7(2):59-67. PubMed ID: 18706288
[TBL] [Abstract][Full Text] [Related]
7. Molecular magnetic resonance imaging of activated platelets allows noninvasive detection of early myocarditis in mice.
Maier A; Braig M; Jakob K; Bienert T; Schäper M; Merkle A; Wadle C; Menza M; Neudorfer I; Bojti I; Stachon P; Duerschmied D; Hilgendorf I; Heidt T; Bode C; Peter K; Klingel K; von Elverfeldt D; von Zur Mühlen C
Sci Rep; 2020 Aug; 10(1):13211. PubMed ID: 32764735
[TBL] [Abstract][Full Text] [Related]
8. A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI.
von Zur Muhlen C; Sibson NR; Peter K; Campbell SJ; Wilainam P; Grau GE; Bode C; Choudhury RP; Anthony DC
J Clin Invest; 2008 Mar; 118(3):1198-207. PubMed ID: 18274670
[TBL] [Abstract][Full Text] [Related]
9. Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging.
Chan JMS; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Cole JE; Goddard M; Cheung MSH; Bhakoo KK; Gibbs RGJ
J Vasc Surg; 2018 May; 67(5):1571-1583.e3. PubMed ID: 28648478
[TBL] [Abstract][Full Text] [Related]
10. Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging.
von Elverfeldt D; Maier A; Duerschmied D; Braig M; Witsch T; Wang X; Mauler M; Neudorfer I; Menza M; Idzko M; Zirlik A; Heidt T; Bronsert P; Bode C; Peter K; von Zur Muhlen C
Circulation; 2014 Aug; 130(8):676-87. PubMed ID: 24951772
[TBL] [Abstract][Full Text] [Related]
11. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
12. A molecular intravascular ultrasound contrast agent allows detection of activated platelets on the surface of symptomatic human plaques.
Maier A; Plaza-Heck P; Meixner F; Guenther F; Kaufmann BA; Kramer M; Heidt T; Zirlik A; Hilgendorf I; Reinöhl J; Stachon P; Bronsert P; Birkemeyer R; Neudorfer I; Peter K; Bode C; von Zur Mühlen C
Atherosclerosis; 2017 Dec; 267():68-77. PubMed ID: 29101838
[TBL] [Abstract][Full Text] [Related]
13. Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.
Guo S; Shen S; Wang J; Wang H; Li M; Liu Y; Hou F; Liao Y; Bin J
Theranostics; 2015; 5(4):418-30. PubMed ID: 25699100
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe.
Klink A; Lancelot E; Ballet S; Vucic E; Fabre JE; Gonzalez W; Medina C; Corot C; Mulder WJ; Mallat Z; Fayad ZA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):403-10. PubMed ID: 20139362
[TBL] [Abstract][Full Text] [Related]
16. Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibody.
Heidt T; Deininger F; Peter K; Goldschmidt J; Pethe A; Hagemeyer CE; Neudorfer I; Zirlik A; Weber WA; Bode C; Meyer PT; Behe M; von Zur Mühlen C
PLoS One; 2011 Mar; 6(3):e18446. PubMed ID: 21479193
[TBL] [Abstract][Full Text] [Related]
17. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
18. Molecular Magnetic Resonance Imaging (mMRI).
Gauberti M; Fournier AP; Vivien D; Martinez de Lizarrondo S
Methods Mol Biol; 2018; 1718():315-327. PubMed ID: 29341017
[TBL] [Abstract][Full Text] [Related]
19. Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis.
Meier S; Pütz G; Massing U; Hagemeyer CE; von Elverfeldt D; Meissner M; Ardipradja K; Barnert S; Peter K; Bode C; Schubert R; von zur Muhlen C
Biomaterials; 2015 Jun; 53():137-48. PubMed ID: 25890714
[TBL] [Abstract][Full Text] [Related]
20. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
